All News

On-demand use of a phosphodiesterase type-5 inhibitor did not affect prostatic or urinary outcomes of therapy for BPH, a post hoc analysis of a large randomized trial showed.

Primary therapy for prostate cancer does not reduce the frequency of end-of-life urologic procedures, according to the findings of a population-based study.

Urologists discuss whether burnout affects them and, if so, what they do to cope.

Here are some resources regarding laws and regulations governing nurse practitioners and physician assistants in your state.

Urologist Catherine R. deVries, MD, has been named a recipient of the American College of Surgeons 2012 Surgical Humanitarian Award.

Uroplasty, Inc. recently announced an expansion of coverage of percutaneous nerve stimulation (PTNS) using its Urgent PC neuromodulation system for the treatment of symptoms of overactive bladder syndrome.

Men with prostate cancer who consumed green tea prior to undergoing prostatectomy had reductions in markers of inflammation, say researchers from UCLA’s David Geffen School of Medicine.

The method of toilet training chosen by parents has no bearing on urinary accidents in children, new research shows.

Patients undergoing treatment for prostate cancer using proton beam therapy reported a higher quality of life in early follow-up but similar QoL scores at 2 years compared to 3-D conformal and intensity-modulated radiation therapy, according to a new study.

Astellas Pharma US, Inc. has announced that mirabegron (Myrbetriq), indicated for the treatment of overactive bladder with symptoms of urge urinary incontinence, urgency, and urinary frequency, is now available through U.S. pharmacies.

As a result of concerns about antibiotic resistance, U.S. physicians are increasingly prescribing quinolones to treat urinary tract infections.

Researchers from Mount Sinai School of Medicine in New York say they have identified a six-gene signature that can be used in a test to predict survival in men with aggressive prostate cancer.

Components of metabolic syndrome have been jointly linked with an increased risk of dying from prostate cancer, according to a recent study.

Chesapeake Urology Associates of Owings Mills, MD and Jersey Shore University Medical Center in Neptune, NJ have announced the appointment of new urologists to their respective practices.

A neobladder reconstruction technique that is performed using robotic assistance appears to be a safe, less invasive option in patients with aggressive bladder cancer.

Recent studies of the oral androgen receptor inhibitor enzalutamide (Xtandi) evaluated the effect of costicosteroid use with the agent as well as its pain-related outcomes in patients with advanced prostate cancer.

Data from a phase III study have linked the advanced prostate cancer drug abiraterone acetate (ZYTIGA) to delayed pain progression and functional decline in a certain subset of advanced prostate cancer patients.

It would appear that the outcome of this year's presidential and congressional elections will be extremely close and will have a significant impact on the delivery of health care in this country, regardless of who the winners are.

The American Institute of Ultrasound in Medicine (AIUM) has granted ultrasound practice accreditation in urology to the Smith Institute for Urology of The North Shore LIJ Health System in New Hyde Park, NY.

Sacral neuromodulation produced efficacy and quality of life results that were superior to standard oral medication in what researchers say is the first study to compare the benefits of the two treatments in a population of less-severe overactive bladder patients.

Recovery from laparo-endoscopic single-site surgery (LESS) was less painful for kidney cancer patients than traditional laparoscopic surgery, according to a recent study by University of California, San Diego researchers.

Contrast-enhanced ultrasound was found to better detect high-grade prostate cancer than conventional methods, report researchers from Thomas Jefferson University and Hospitals, Philadelphia.

A one-time onabotulinumtoxinA (Botox) injection in the bladder worked as well as daily anticholinergic drugs for reducing episodes of urinary incontinence, and was more effective in completely resolving symptoms, according to a recent study.

The American College of Surgeons Board of Regents has presented urologist Jack W. McAninch, MD, with the College’s 2012 Distinguished Service Award.

AVEO Oncology has submitted a new drug application to the FDA seeking approval for tivozanib in patients with advanced renal cell carcinoma.

Two recent studies shed new light on the mechanism of maintaining an erection and genetic markers linked to erectile dysfunction after radiation therapy.

The AUA and the American Association of Clinical Urologists have announced a new agreement for UROPAC, the urology political action committee.

Adding endorectal magnetic resonance imaging to the initial clinical evaluation of men with clinically low prostate cancer risk helps assess these patients' eligibility for active surveillance, according to a recent study.